Braun Robert N, Halhuber Max J, Hitzenberger Gerhart
Arbeitsgemeinschaft zur Erforschung-der Allgemeinmedizin, Lüt-zowgasse 6/3/21, A-1140 Wien.
Wien Med Wochenschr. 2003;153(3-4):80-2. doi: 10.1046/j.1563-258x.2003.02029.x.
A worldwide frequently applied HMG-CoA-reductase-inhibitor ("statin") recently has been withdrawn from the market. This obviously has been caused by serious adverse events. The question is whether the package inserts sufficiently inform about the risks. But, although they list up numerous side effects, they lack informations concerning the frequency of them, so the patients when reading the package inserts become confused. Thus they have to rely on their doctors choice regarding the danger outlined in the inserts. In that respect packing inserts could be improved.
一种在全球广泛应用的HMG-CoA还原酶抑制剂（“他汀类药物”）最近已被撤出市场。这显然是由严重的不良事件导致的。问题在于药品说明书是否充分告知了相关风险。但是，尽管它们列出了众多副作用，却缺乏关于这些副作用发生频率的信息，所以患者在阅读药品说明书时会感到困惑。因此，他们不得不依赖医生对说明书中所述风险的判断。在这方面，药品说明书是可以改进的。
